FDA Inspection 1210731 — Eric Sicard, M.D.
The FDA completed an inspection of Eric Sicard, M.D. on June 16, 2023 in Mont-Royal. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 16, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Mont-Royal (Canada)
Additional Details
Clinical BA/BE